购物车
- 全部删除
- 您的购物车当前为空
CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM in Ca2+ flux assay).
为众多的药物研发团队赋能,
让新药发现更简单!
CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM in Ca2+ flux assay).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 2,570 | 5日内发货 | |
5 mg | ¥ 3,150 | 5日内发货 | |
25 mg | ¥ 10,800 | 10-14周 | |
50 mg | ¥ 14,100 | 10-14周 | |
100 mg | ¥ 21,900 | 10-14周 | |
1 mL x 10 mM (in DMSO) | ¥ 3,780 | 5日内发货 |
产品描述 | CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM in Ca2+ flux assay). |
靶点活性 | CCR1:1.8 nM (in Ca2+ flux assay) |
分子量 | 451.47 |
分子式 | C22H18FN5O3S |
CAS No. | 1295298-26-8 |
密度 | 1.51 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容